癌症治疗反应的微环境调节
Microenvironmental regulation of therapeutic response in cancer.
作者信息
Klemm Florian, Joyce Johanna A
机构信息
Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
出版信息
Trends Cell Biol. 2015 Apr;25(4):198-213. doi: 10.1016/j.tcb.2014.11.006. Epub 2014 Dec 22.
Abstract
The tumor microenvironment (TME) not only plays a pivotal role during cancer progression and metastasis but also has profound effects on therapeutic efficacy. In the case of microenvironment-mediated resistance this can involve an intrinsic response, including the co-option of pre-existing structural elements and signaling networks, or an acquired response of the tumor stroma following the therapeutic insult. Alternatively, in other contexts, the TME has a multifaceted ability to enhance therapeutic efficacy. This review examines recent advances in our understanding of the contribution of the TME during cancer therapy and discusses key concepts that may be amenable to therapeutic intervention.
摘要
肿瘤微环境（TME）不仅在癌症进展和转移过程中起关键作用，而且对治疗效果也有深远影响。在微环境介导的耐药情况下，这可能涉及一种内在反应，包括对预先存在的结构元件和信号网络的利用，或者是肿瘤基质在治疗损伤后的获得性反应。或者，在其他情况下，TME具有多方面增强治疗效果的能力。本综述探讨了我们对TME在癌症治疗中的作用的最新认识进展，并讨论了可能适合进行治疗干预的关键概念。
相似文献
1
Microenvironmental regulation of therapeutic response in cancer.癌症治疗反应的微环境调节
Trends Cell Biol. 2015 Apr;25(4):198-213. doi: 10.1016/j.tcb.2014.11.006. Epub 2014 Dec 22.
2
The Microenvironment of Lung Cancer and Therapeutic Implications.肺癌的微环境及其治疗意义
Adv Exp Med Biol. 2016;890:75-110. doi: 10.1007/978-3-319-24932-2_5.
3
[Tumor microenvironment: promising therapeutic target].[肿瘤微环境：颇具前景的治疗靶点]
Nihon Rinsho. 2015 Aug;73(8):1283-7.
4
Fighting the force: Potential of homeobox genes for tumor microenvironment regulation.对抗这种力量：同源框基因对肿瘤微环境的调控潜力
Biochim Biophys Acta. 2015 Apr;1855(2):248-53. doi: 10.1016/j.bbcan.2015.03.004. Epub 2015 Mar 24.
5
Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.前列腺癌进展的分子见解：肿瘤微环境的缺失环节
J Urol. 2005 Jan;173(1):10-20. doi: 10.1097/01.ju.0000141582.15218.10.
6
DNA methylation in the tumor microenvironment.肿瘤微环境中的DNA甲基化。
J Zhejiang Univ Sci B. 2017 May;18(5):365-372. doi: 10.1631/jzus.B1600579.
7
[Tumor microenvironment and therapeutic resistance process].[肿瘤微环境与治疗抵抗过程]
Med Sci (Paris). 2014 Apr;30(4):445-51. doi: 10.1051/medsci/20143004021. Epub 2014 May 5.
8
Impact of tumor microenvironment composition on therapeutic responses and clinical outcomes in cancer.肿瘤微环境组成对癌症治疗反应和临床结局的影响。
Future Oncol. 2018 Jun;14(14):1409-1421. doi: 10.2217/fon-2017-0585. Epub 2018 May 31.
9
Can Targeting Stroma Pave the Way to Enhanced Antitumor Immunity and Immunotherapy of Solid Tumors?靶向基质是否能为增强实体瘤抗肿瘤免疫和免疫治疗铺平道路？
Cancer Immunol Res. 2016 Apr;4(4):269-78. doi: 10.1158/2326-6066.CIR-16-0011.
10
Radiation-Induced Transformation of Immunoregulatory Networks in the Tumor Stroma.肿瘤基质中免疫调节网络的辐射诱导转化。
Front Immunol. 2018 Jul 26;9:1679. doi: 10.3389/fimmu.2018.01679. eCollection 2018.
引用本文的文献
1
Pan-Cancer Computational Analysis of RKIP () and LKB1 () Co-Expression Highlights Distinct Immunometabolic Dynamics and Therapeutic Responses Within the Tumor Microenvironment.RKIP（）和LKB1（）共表达的泛癌计算分析突出了肿瘤微环境中不同的免疫代谢动态和治疗反应。
Int J Mol Sci. 2025 Jul 24;26(15):7145. doi: 10.3390/ijms26157145.
2
Ginkgetin from Ginkgo biloba: mechanistic insights into anticancer efficacy.银杏中的银杏双黄酮：抗癌功效的作用机制洞察
Nat Prod Bioprospect. 2025 Aug 5;15(1):50. doi: 10.1007/s13659-025-00535-6.
3
A novel organoid model retaining the glioma microenvironment for personalized drug screening and therapeutic evaluation.一种保留胶质瘤微环境用于个性化药物筛选和治疗评估的新型类器官模型。
Bioact Mater. 2025 Jul 14;53:205-217. doi: 10.1016/j.bioactmat.2025.07.015. eCollection 2025 Nov.
4
Stemness signatures reflect prognostic disturbances in gastric cancer.干性特征反映了胃癌中的预后紊乱。
World J Gastrointest Oncol. 2025 Jul 15;17(7):107211. doi: 10.4251/wjgo.v17.i7.107211.
5
Disruption of cell-intrinsic PCSK9 enhances the antitumor efficacy of CD8 T cells.细胞内源性前蛋白转化酶枯草溶菌素9（PCSK9）的破坏增强了CD8 T细胞的抗肿瘤功效。
J Immunother Cancer. 2025 Jul 15;13(7):e011657. doi: 10.1136/jitc-2025-011657.
6
Radiation Therapy Personalization in Cancer Treatment: Strategies and Perspectives.癌症治疗中的放射治疗个体化：策略与展望
Int J Mol Sci. 2025 Jul 2;26(13):6375. doi: 10.3390/ijms26136375.
7
Ex vivo model of functioning human lymph node reveals role for innate lymphocytes and stroma in response to vaccine adjuvant.功能性人类淋巴结的体外模型揭示了天然淋巴细胞和基质在疫苗佐剂反应中的作用。
Cell Rep. 2025 Jul 22;44(7):115938. doi: 10.1016/j.celrep.2025.115938. Epub 2025 Jul 2.
8
[Correlations of immune cell infiltration characteristics with clinicopathological parameters in patients with clear cell renal cell carcinoma].[透明细胞肾细胞癌患者免疫细胞浸润特征与临床病理参数的相关性]
Nan Fang Yi Ke Da Xue Xue Bao. 2025 Jun 20;45(6):1280-1288. doi: 10.12122/j.issn.1673-4254.2025.06.17.
9
Mitochondrial transplantation sensitizes chemotherapy to inhibit tumor development by enhancing anti-tumor immunity.线粒体移植通过增强抗肿瘤免疫力使化疗更有效地抑制肿瘤发展。
Cancer Biol Med. 2025 Jun 19;22(6):648-71. doi: 10.20892/j.issn.2095-3941.2024.0596.
10
Targeted Lung Premetastasis Niche: Mechanisms, Strategies, and Application.靶向肺转移前微环境：机制、策略与应用
MedComm (2020). 2025 Jun 3;6(6):e70248. doi: 10.1002/mco2.70248. eCollection 2025 Jun.
本文引用的文献
1
Exosome transfer from stromal to breast cancer cells regulates therapy resistance pathways.外泌体从基质细胞向乳腺癌细胞的转移调节治疗抗性途径。
Cell. 2014 Oct 23;159(3):499-513. doi: 10.1016/j.cell.2014.09.051.
2
CSF1/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer models.在胰腺癌模型中，CSF1/CSF1R阻断可重编程肿瘤浸润巨噬细胞并改善对T细胞检查点免疫疗法的反应。
Cancer Res. 2014 Sep 15;74(18):5057-69. doi: 10.1158/0008-5472.CAN-13-3723. Epub 2014 Jul 31.
3
Endothelial-cell FAK targeting sensitizes tumours to DNA-damaging therapy.靶向内皮细胞 FAK 可提高肿瘤对 DNA 损伤治疗的敏感性。
Nature. 2014 Oct 2;514(7520):112-6. doi: 10.1038/nature13541. Epub 2014 Jul 27.
4
Therapeutic targeting of tumor-associated macrophages and microglia in glioblastoma.胶质母细胞瘤中肿瘤相关巨噬细胞和小胶质细胞的治疗靶点
Immunotherapy. 2014;6(6):663-6. doi: 10.2217/imt.14.48.
5
Systematic review: the role of the gut microbiota in chemotherapy- or radiation-induced gastrointestinal mucositis - current evidence and potential clinical applications.系统评价：肠道微生物群在化疗或放疗引起的胃肠道黏膜炎中的作用——当前证据及潜在临床应用
Aliment Pharmacol Ther. 2014 Sep;40(5):409-21. doi: 10.1111/apt.12878. Epub 2014 Jul 11.
6
Metabolic reprogramming of stromal fibroblasts through p62-mTORC1 signaling promotes inflammation and tumorigenesis.通过 p62-mTORC1 信号对基质成纤维细胞进行代谢重编程可促进炎症和肿瘤发生。
Cancer Cell. 2014 Jul 14;26(1):121-135. doi: 10.1016/j.ccr.2014.05.004. Epub 2014 Jul 4.
7
The metabolic cooperation between cells in solid cancer tumors.实体癌肿瘤中细胞间的代谢合作。
Biochim Biophys Acta. 2014 Aug;1846(1):216-25. doi: 10.1016/j.bbcan.2014.06.002. Epub 2014 Jun 28.
8
Leukemia propagating cells rebuild an evolving niche in response to therapy.白血病增殖细胞对治疗产生反应，重新构建不断演变的龛位。
Cancer Cell. 2014 Jun 16;25(6):778-93. doi: 10.1016/j.ccr.2014.04.015.
9
Antitumor efficacy of the anti-interleukin-6 (IL-6) antibody siltuximab in mouse xenograft models of lung cancer.抗白细胞介素-6（IL-6）抗体西妥昔单抗在肺癌小鼠异种移植模型中的抗肿瘤疗效。
J Thorac Oncol. 2014 Jul;9(7):974-982. doi: 10.1097/JTO.0000000000000193.
10
B cells regulate macrophage phenotype and response to chemotherapy in squamous carcinomas.B 细胞调节鳞状细胞癌中巨噬细胞的表型和对化疗的反应。
Cancer Cell. 2014 Jun 16;25(6):809-821. doi: 10.1016/j.ccr.2014.04.026. Epub 2014 Jun 5.
Zotero 插件